We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.42T
$21.5M 2.09%
29,131
+19,944
+217% +$12.3M
GLD icon
2
SPDR Gold Trust
GLD
$131B
$19.6M 1.91%
64,441
-10,100
-14% -$3.06M
NVDA icon
3
NVIDIA
NVDA
$4.86T
$19.5M 1.89%
123,149
+69,343
+129% +$8.73M
BHF icon
4
Brighthouse Financial
BHF
$3.56B
$14.9M 1.45%
277,651
+7,820
+3% +$440K
TSLA icon
5
Tesla
TSLA
$1.23T
$12.9M 1.25%
40,524
+33,050
+442% +$9.96M
GTM
6
ZoomInfo Technologies
GTM
$973M
$11.8M 1.15%
1,167,122
+538,547
+86% +$4.98M
HYG icon
7
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$11.8M 1.14%
145,824
+131,561
+922% +$10.4M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.36T
$11.7M 1.13%
+65,723
New +$10.9M
BIDU icon
9
Baidu
BIDU
$37.7B
$10.9M 1.06%
127,052
+15,994
+14% +$1.38M
K
10
DELISTED
Kellanova
K
$9.85M 0.96%
123,811
-25,400
-17% -$2.08M
AMED
11
DELISTED
Amedisys
AMED
$8.89M 0.86%
90,361
+36,974
+69% +$3.5M
ANF icon
12
Abercrombie & Fitch
ANF
$4.42B
$8.6M 0.84%
103,771
+46,363
+81% +$3.52M
FLR icon
13
Fluor
FLR
$7.01B
$8.58M 0.83%
+167,275
New +$6.67M
HES
14
DELISTED
Hess
HES
$8.08M 0.79%
58,320
-16,763
-22% -$2.26M
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
$8.07M 0.78%
171,716
+140,533
+451% +$6.25M
BPMC
16
DELISTED
Blueprint Medicines
BPMC
$7.71M 0.75%
+60,154
New +$6.25M
MSFT icon
17
Microsoft
MSFT
$3.45T
$7.35M 0.71%
14,770
-448
-3% -$195K
FYBR
18
DELISTED
Frontier Communications
FYBR
$7.28M 0.71%
199,914
-50,525
-20% -$1.83M
TLT icon
19
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$7.08M 0.69%
80,200
+69,271
+634% +$6.04M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.71B
$7.06M 0.69%
29,267
-870
-3% -$206K
CORZ icon
21
Core Scientific
CORZ
$6.66B
$6.91M 0.67%
404,835
-635,191
-61% -$6.36M
CNR
22
Core Natural Resources Inc
CNR
$4.02B
$6.7M 0.65%
96,037
-1,688
-2% -$120K
PENN icon
23
PENN Entertainment
PENN
$2.75B
$6.28M 0.61%
351,693
+31,715
+10% +$498K
NFLX icon
24
Netflix
NFLX
$299B
$5.78M 0.56%
43,160
+18,080
+72% +$2.04M
KD icon
25
Kyndryl
KD
$2.99B
$5.57M 0.54%
132,748
-58,151
-30% -$2.1M

Similar funds

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.